Back
  1. Home
  2. Profile of Marilèna LA MARCA (ULiège)
Profil

LA MARCA Marilèna

Département de gestion des systèmes d'informations (GSI) > Secteur codage et nomenclature

See author's contact details
Main Referenced Co-authors
Demols, A. (1)
Gay, F. (1)
Hendlisz, A. (1)
Marechal, R. (1)
Monsaert, E. (1)
Main Referenced Keywords
advanced and metastatic pancreatic cancer (1); gemcitabine plus oxaliplatin (1); second line chemotherapy (1);
Main Referenced Disciplines
Oncology (1)

Publications (total 1)

The most downloaded
23 downloads
Demols, A., La Marca, M., Polus, M., Marechal, R., Gay, F., Monsaert, E., Hendlisz, A., & Van Laethem, J. L. (27 February 2006). Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. British Journal of Cancer, 94 (4), 481-485. doi:10.1038/sj.bjc.6602966 https://hdl.handle.net/2268/257224

The most cited

124 citations (Scopus®)

Demols, A., La Marca, M., Polus, M., Marechal, R., Gay, F., Monsaert, E., Hendlisz, A., & Van Laethem, J. L. (27 February 2006). Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. British Journal of Cancer, 94 (4), 481-485. doi:10.1038/sj.bjc.6602966 https://hdl.handle.net/2268/257224

Demols, A., La Marca, M., Polus, M., Marechal, R., Gay, F., Monsaert, E., Hendlisz, A., & Van Laethem, J. L. (27 February 2006). Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. British Journal of Cancer, 94 (4), 481-485. doi:10.1038/sj.bjc.6602966
Peer Reviewed verified by ORBi

Contact ORBi